C2346621_NCI_FDA | Knowledge4COVID-19

Property	Value
?:definition	A biomarker that is measured in an analytical test system with well-established performance characteristics and for which there is widespread agreement in the medical or scientific community about the physiologic, toxicologic, pharmacologic, or clinical significance of the results (From: Pharmacogenomic Data Submissions, FDA Guidance for Industry.)
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C2346621>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_FDA>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C2346621_NCI_FDA>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C2346621_NCI_FDA>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all